Impact of the MELD allocation after its implementation in liver transplantation

References

• Jung GE, Encke J, Schmidt J, Rahmel A. [Model for end-stage liver disease. New basis of allocation for liver transplantations]. Chirurg 2008;79(2):157–63.
   PubMed Web of Science ®Google Scholar
• Freeman RB Jr, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 2000;6(5):543–52.
   PubMed Web of Science ®Google Scholar
• Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006;12(7):1049–61.
   PubMed Web of Science ®Google Scholar
• Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31(4):864–71.
   PubMed Web of Science ®Google Scholar
• Freeman RB, Harper AM, Edwards EB. Redrawing organ distribution boundaries: results of a computer-simulated analysis for liver transplantation. Liver Transpl 2002;8(8):659–66.
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33(2):464–70.
   PubMed Web of Science ®Google Scholar
• Freeman RB. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection. Liver Transpl 2004;10(10 Suppl 2):S2–3.
   PubMed Web of Science ®Google Scholar
• Nagler E, Van VH, Colle I, Troisi R, de HB. Impact of MELD on short-term and long-term outcome following liver transplantation: a European perspective. Eur J Gastroenterol Hepatol 2005;17(8):849–56.
   PubMed Web of Science ®Google Scholar
• de la MM, Cuende N, Huet J, Bernardos A, Ferron JA, Santoyo J, Model for end-stage liver disease score-based allocation of donors for liver transplantation: a Spanish multicenter experience. Transplantation 2006;82(11):1429–35.
   PubMed Web of Science ®Google Scholar
• Brandao A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G. MELD and other predictors of survival after liver transplantation. Clin Transplant 2009;23(2):220–7.
   PubMed Web of Science ®Google Scholar
• Weismuller TJ, Prokein J, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol 2008;43(6):736–46.
   PubMed Web of Science ®Google Scholar
• Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009;9(2):318–26.
   PubMed Web of Science ®Google Scholar
• Hanto DW, Fishbein TM, Pinson CW, Olthoff KM, Shiffman ML, Punch JD, Liver and intestine transplantation: summary analysis, 1994–2003. Am J Transplant 2005;5(4 Pt 2):916–33.
   PubMed Web of Science ®Google Scholar
• Olthoff KM, Brown RS Jr, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl 2004;10(10 Suppl 2):A6–22.
   PubMed Web of Science ®Google Scholar
• Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl 2004;10(5):621–30.
   PubMed Web of Science ®Google Scholar
• Foster R, Zimmerman M, Trotter JF. Expanding donor options: marginal, living, and split donors. Clin Liver Dis 2007;11(2):417–29.
   PubMedGoogle Scholar
• Freeman RB. Mathematical models and behavior: assessing delta MELD for liver allocation. Am J Transplant 2004;4(11):1735–6.
   PubMed Web of Science ®Google Scholar
• Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S. Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl 2009;15(11):1570–8.
   PubMed Web of Science ®Google Scholar
• Washburn WK, Pollock BH, Nichols L, Speeg KV, Halff G. Impact of recipient MELD score on resource utilization. Am J Transplant 2006;6(10):2449–54.
   PubMed Web of Science ®Google Scholar
• Merion RM. When is a patient too well and when is a patient too sick for a liver transplant? Liver Transpl 2004;10(10 Suppl 2):S69–73.
   PubMed Web of Science ®Google Scholar
• Freeman RB Jr. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology 2008;47(3):1052–7.
   PubMed Web of Science ®Google Scholar
• Weismuller TJ, Negm A, Becker T, Barg-Hock H, Klempnauer J, Manns MP, The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics. Transpl Int 2009;22(10):970–8.
   PubMed Web of Science ®Google Scholar
• Habib S, Berk B, Chang CC, Demetris AJ, Fontes P, Dvorchik I, MELD and prediction of post-liver transplantation survival. Liver Transpl 2006;12(3):440–7.
   PubMed Web of Science ®Google Scholar
• Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9(2):117–23.
   PubMed Web of Science ®Google Scholar
• Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10(1):7–15.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Downey KK, Akoad M, Cacciarelli TV. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Liver Transpl 2007;13(11):1564–9.
   PubMed Web of Science ®Google Scholar
• Weismuller TJ, Fikatas P, Schmidt J, Barreiros AP, Otto G, Beckebaum S, Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany – limitations of the ’sickest first‘ – concept. Transpl Int 2011;24(1):91–9.
   PubMed Web of Science ®Google Scholar
• Nadalin S, Schaffer R, Fruehauf N. Split-liver transplantation in the high-MELD adult patient: are we being too cautious? Transpl Int 2009;22(7):702–6.
   PubMed Web of Science ®Google Scholar
• Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, Live donor liver transplantation in high MELD score recipients. Ann Surg 2010;251(1):153–7.
   PubMed Web of Science ®Google Scholar
• Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Liver Transpl 2009;15(5):496–503.
   PubMed Web of Science ®Google Scholar
• Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2003;9(7):737–40.
   PubMed Web of Science ®Google Scholar
• Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130(6):1652–60.
   PubMed Web of Science ®Google Scholar
• Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008;8(12):2537–46.
   PubMed Web of Science ®Google Scholar